Global Recombinant Human Follicle-stimulating Hormone Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 104
Published Date: 08 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Recombinant Human Follicle-stimulating Hormone market size was valued at USD 1075.9 million in 2023 and is forecast to a readjusted size of USD 1550.5 million by 2030 with a CAGR of 5.4% during review period.
Recombinant Human Follicle-Stimulating Hormone (r-hFSH) is a biotechnologically produced hormone that plays a crucial role in the human reproductive system. It is a synthetic form of the naturally occurring follicle-stimulating hormone (FSH), which is produced by the anterior pituitary gland in the brain. FSH is essential for the regulation of the female and male reproductive systems and is involved in processes like ovarian follicle development, sperm production, and the maturation of reproductive cells.
Increasing Demand for Assisted Reproductive Technologies (ART): The growing acceptance of ART, including in vitro fertilization (IVF), is driving the demand for r-hFSH. ART is used by individuals and couples to address infertility issues, and r-hFSH plays a vital role in controlled ovarian stimulation.
Advancements in ART Procedures: Ongoing advancements in ART procedures are leading to increased use of r-hFSH. These procedures continue to improve success rates, which further fuels demand.
Expanded Indications: The use of r-hFSH is being explored for a broader range of indications, including for individuals with specific hormonal imbalances or other medical conditions that affect reproductive health.
Personalized Medicine: Tailoring treatment regimens to individual patients is gaining importance. Clinicians are increasingly using r-hFSH in personalized fertility treatment plans, optimizing the chances of success while minimizing side effects.
Global Expansion: The use of r-hFSH is expanding globally as countries invest in reproductive healthcare infrastructure. Emerging markets are showing increased demand for fertility treatments and related products.
The Global Info Research report includes an overview of the development of the Recombinant Human Follicle-stimulating Hormone industry chain, the market status of Infertility Treatment (75IU, 150IU), Assisted Reproductive Technology (75IU, 150IU), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant Human Follicle-stimulating Hormone.
Regionally, the report analyzes the Recombinant Human Follicle-stimulating Hormone markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant Human Follicle-stimulating Hormone market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Recombinant Human Follicle-stimulating Hormone market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant Human Follicle-stimulating Hormone industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., 75IU, 150IU).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant Human Follicle-stimulating Hormone market.
Regional Analysis: The report involves examining the Recombinant Human Follicle-stimulating Hormone market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant Human Follicle-stimulating Hormone market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Recombinant Human Follicle-stimulating Hormone:
Company Analysis: Report covers individual Recombinant Human Follicle-stimulating Hormone players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant Human Follicle-stimulating Hormone This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infertility Treatment, Assisted Reproductive Technology).
Technology Analysis: Report covers specific technologies relevant to Recombinant Human Follicle-stimulating Hormone. It assesses the current state, advancements, and potential future developments in Recombinant Human Follicle-stimulating Hormone areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant Human Follicle-stimulating Hormone market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Recombinant Human Follicle-stimulating Hormone market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
75IU
150IU
Others
Market segment by Application
Infertility Treatment
Assisted Reproductive Technology
Market segment by players, this report covers
Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Recombinant Human Follicle-stimulating Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Recombinant Human Follicle-stimulating Hormone, with revenue, gross margin and global market share of Recombinant Human Follicle-stimulating Hormone from 2019 to 2024.
Chapter 3, the Recombinant Human Follicle-stimulating Hormone competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Recombinant Human Follicle-stimulating Hormone market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Human Follicle-stimulating Hormone.
Chapter 13, to describe Recombinant Human Follicle-stimulating Hormone research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Recombinant Human Follicle-stimulating Hormone
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Recombinant Human Follicle-stimulating Hormone by Type
1.3.1 Overview: Global Recombinant Human Follicle-stimulating Hormone Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type in 2023
1.3.3 75IU
1.3.4 150IU
1.3.5 Others
1.4 Global Recombinant Human Follicle-stimulating Hormone Market by Application
1.4.1 Overview: Global Recombinant Human Follicle-stimulating Hormone Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infertility Treatment
1.4.3 Assisted Reproductive Technology
1.5 Global Recombinant Human Follicle-stimulating Hormone Market Size & Forecast
1.6 Global Recombinant Human Follicle-stimulating Hormone Market Size and Forecast by Region
1.6.1 Global Recombinant Human Follicle-stimulating Hormone Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Recombinant Human Follicle-stimulating Hormone Market Size by Region, (2019-2030)
1.6.3 North America Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2019-2030)
1.6.4 Europe Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2019-2030)
1.6.6 South America Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Size and Prospect (2019-2030)
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.1.4 Merck Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments and Future Plans
2.2 Ferring
2.2.1 Ferring Details
2.2.2 Ferring Major Business
2.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.2.4 Ferring Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Ferring Recent Developments and Future Plans
2.3 Livzon
2.3.1 Livzon Details
2.3.2 Livzon Major Business
2.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.3.4 Livzon Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Livzon Recent Developments and Future Plans
2.4 Gedeon Richter
2.4.1 Gedeon Richter Details
2.4.2 Gedeon Richter Major Business
2.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.4.4 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Gedeon Richter Recent Developments and Future Plans
2.5 GenSci
2.5.1 GenSci Details
2.5.2 GenSci Major Business
2.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.5.4 GenSci Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GenSci Recent Developments and Future Plans
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.6.4 Teva Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Teva Recent Developments and Future Plans
2.7 ChangChun High & New Technology
2.7.1 ChangChun High & New Technology Details
2.7.2 ChangChun High & New Technology Major Business
2.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.7.4 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 ChangChun High & New Technology Recent Developments and Future Plans
2.8 ABL
2.8.1 ABL Details
2.8.2 ABL Major Business
2.8.3 ABL Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.8.4 ABL Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 ABL Recent Developments and Future Plans
2.9 Scripps Laboratories
2.9.1 Scripps Laboratories Details
2.9.2 Scripps Laboratories Major Business
2.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.9.4 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Scripps Laboratories Recent Developments and Future Plans
2.10 Alphamab Oncology
2.10.1 Alphamab Oncology Details
2.10.2 Alphamab Oncology Major Business
2.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.10.4 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Alphamab Oncology Recent Developments and Future Plans
2.11 Hunan Jingfeng Pharmaceutical
2.11.1 Hunan Jingfeng Pharmaceutical Details
2.11.2 Hunan Jingfeng Pharmaceutical Major Business
2.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.11.4 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hunan Jingfeng Pharmaceutical Recent Developments and Future Plans
2.12 Qilu Pharmaceutical
2.12.1 Qilu Pharmaceutical Details
2.12.2 Qilu Pharmaceutical Major Business
2.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.12.4 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Qilu Pharmaceutical Recent Developments and Future Plans
2.13 Beijing SL Pharmaceutical
2.13.1 Beijing SL Pharmaceutical Details
2.13.2 Beijing SL Pharmaceutical Major Business
2.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
2.13.4 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Beijing SL Pharmaceutical Recent Developments and Future Plans
3.1 Global Recombinant Human Follicle-stimulating Hormone Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Recombinant Human Follicle-stimulating Hormone by Company Revenue
3.2.2 Top 3 Recombinant Human Follicle-stimulating Hormone Players Market Share in 2023
3.2.3 Top 6 Recombinant Human Follicle-stimulating Hormone Players Market Share in 2023
3.3 Recombinant Human Follicle-stimulating Hormone Market: Overall Company Footprint Analysis
3.3.1 Recombinant Human Follicle-stimulating Hormone Market: Region Footprint
3.3.2 Recombinant Human Follicle-stimulating Hormone Market: Company Product Type Footprint
3.3.3 Recombinant Human Follicle-stimulating Hormone Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Recombinant Human Follicle-stimulating Hormone Consumption Value and Market Share by Type (2019-2024)
4.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Type (2025-2030)
5.1 Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2019-2024)
5.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Application (2025-2030)
6.1 North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2030)
6.2 North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2030)
6.3 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country
6.3.1 North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2019-2030)
6.3.2 United States Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
6.3.3 Canada Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
6.3.4 Mexico Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
7.1 Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2030)
7.2 Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2030)
7.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country
7.3.1 Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2019-2030)
7.3.2 Germany Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
7.3.3 France Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
7.3.5 Russia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
7.3.6 Italy Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region
8.3.1 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2019-2030)
8.3.2 China Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
8.3.3 Japan Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
8.3.4 South Korea Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
8.3.5 India Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
8.3.7 Australia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
9.1 South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2030)
9.2 South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2030)
9.3 South America Recombinant Human Follicle-stimulating Hormone Market Size by Country
9.3.1 South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2019-2030)
9.3.2 Brazil Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
9.3.3 Argentina Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country
10.3.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2019-2030)
10.3.2 Turkey Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
10.3.4 UAE Recombinant Human Follicle-stimulating Hormone Market Size and Forecast (2019-2030)
11.1 Recombinant Human Follicle-stimulating Hormone Market Drivers
11.2 Recombinant Human Follicle-stimulating Hormone Market Restraints
11.3 Recombinant Human Follicle-stimulating Hormone Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Recombinant Human Follicle-stimulating Hormone Industry Chain
12.2 Recombinant Human Follicle-stimulating Hormone Upstream Analysis
12.3 Recombinant Human Follicle-stimulating Hormone Midstream Analysis
12.4 Recombinant Human Follicle-stimulating Hormone Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Merck Company Information, Head Office, and Major Competitors
Table 6. Merck Major Business
Table 7. Merck Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 8. Merck Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Merck Recent Developments and Future Plans
Table 10. Ferring Company Information, Head Office, and Major Competitors
Table 11. Ferring Major Business
Table 12. Ferring Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 13. Ferring Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Ferring Recent Developments and Future Plans
Table 15. Livzon Company Information, Head Office, and Major Competitors
Table 16. Livzon Major Business
Table 17. Livzon Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 18. Livzon Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Livzon Recent Developments and Future Plans
Table 20. Gedeon Richter Company Information, Head Office, and Major Competitors
Table 21. Gedeon Richter Major Business
Table 22. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 23. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Gedeon Richter Recent Developments and Future Plans
Table 25. GenSci Company Information, Head Office, and Major Competitors
Table 26. GenSci Major Business
Table 27. GenSci Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 28. GenSci Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GenSci Recent Developments and Future Plans
Table 30. Teva Company Information, Head Office, and Major Competitors
Table 31. Teva Major Business
Table 32. Teva Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 33. Teva Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Teva Recent Developments and Future Plans
Table 35. ChangChun High & New Technology Company Information, Head Office, and Major Competitors
Table 36. ChangChun High & New Technology Major Business
Table 37. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 38. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. ChangChun High & New Technology Recent Developments and Future Plans
Table 40. ABL Company Information, Head Office, and Major Competitors
Table 41. ABL Major Business
Table 42. ABL Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 43. ABL Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. ABL Recent Developments and Future Plans
Table 45. Scripps Laboratories Company Information, Head Office, and Major Competitors
Table 46. Scripps Laboratories Major Business
Table 47. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 48. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Scripps Laboratories Recent Developments and Future Plans
Table 50. Alphamab Oncology Company Information, Head Office, and Major Competitors
Table 51. Alphamab Oncology Major Business
Table 52. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 53. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Alphamab Oncology Recent Developments and Future Plans
Table 55. Hunan Jingfeng Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. Hunan Jingfeng Pharmaceutical Major Business
Table 57. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 58. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Hunan Jingfeng Pharmaceutical Recent Developments and Future Plans
Table 60. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 61. Qilu Pharmaceutical Major Business
Table 62. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 63. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Qilu Pharmaceutical Recent Developments and Future Plans
Table 65. Beijing SL Pharmaceutical Company Information, Head Office, and Major Competitors
Table 66. Beijing SL Pharmaceutical Major Business
Table 67. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product and Solutions
Table 68. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Beijing SL Pharmaceutical Recent Developments and Future Plans
Table 70. Global Recombinant Human Follicle-stimulating Hormone Revenue (USD Million) by Players (2019-2024)
Table 71. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Players (2019-2024)
Table 72. Breakdown of Recombinant Human Follicle-stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Recombinant Human Follicle-stimulating Hormone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Recombinant Human Follicle-stimulating Hormone Players
Table 75. Recombinant Human Follicle-stimulating Hormone Market: Company Product Type Footprint
Table 76. Recombinant Human Follicle-stimulating Hormone Market: Company Product Application Footprint
Table 77. Recombinant Human Follicle-stimulating Hormone New Market Entrants and Barriers to Market Entry
Table 78. Recombinant Human Follicle-stimulating Hormone Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Recombinant Human Follicle-stimulating Hormone Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Share by Type (2019-2024)
Table 81. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Forecast by Type (2025-2030)
Table 82. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2024)
Table 83. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Forecast by Application (2025-2030)
Table 84. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Recombinant Human Follicle-stimulating Hormone Raw Material
Table 115. Key Suppliers of Recombinant Human Follicle-stimulating Hormone Raw Materials
List of Figures
Figure 1. Recombinant Human Follicle-stimulating Hormone Picture
Figure 2. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type in 2023
Figure 4. 75IU
Figure 5. 150IU
Figure 6. Others
Figure 7. Global Recombinant Human Follicle-stimulating Hormone Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application in 2023
Figure 9. Infertility Treatment Picture
Figure 10. Assisted Reproductive Technology Picture
Figure 11. Global Recombinant Human Follicle-stimulating Hormone Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Recombinant Human Follicle-stimulating Hormone Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Recombinant Human Follicle-stimulating Hormone Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Region in 2023
Figure 16. North America Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Players in 2023
Figure 22. Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Recombinant Human Follicle-stimulating Hormone Market Share in 2023
Figure 24. Global Top 6 Players Recombinant Human Follicle-stimulating Hormone Market Share in 2023
Figure 25. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Share by Type (2019-2024)
Figure 26. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Type (2025-2030)
Figure 27. Global Recombinant Human Follicle-stimulating Hormone Consumption Value Share by Application (2019-2024)
Figure 28. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Application (2025-2030)
Figure 29. North America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 39. France Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Region (2019-2030)
Figure 46. China Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 49. India Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Recombinant Human Follicle-stimulating Hormone Consumption Value (2019-2030) & (USD Million)
Figure 63. Recombinant Human Follicle-stimulating Hormone Market Drivers
Figure 64. Recombinant Human Follicle-stimulating Hormone Market Restraints
Figure 65. Recombinant Human Follicle-stimulating Hormone Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Recombinant Human Follicle-stimulating Hormone in 2023
Figure 68. Manufacturing Process Analysis of Recombinant Human Follicle-stimulating Hormone
Figure 69. Recombinant Human Follicle-stimulating Hormone Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Merck Ferring Livzon Gedeon Richter GenSci Teva ChangChun High & New Technology ABL Scripps Laboratories Alphamab Oncology Hunan Jingfeng Pharmaceutical Qilu Pharmaceutical Beijing SL Pharmaceutical
Related Reports
19 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
